Evaluation of Efficacy and Safety of Endoscopic Hemostasis with PuraStat in Colonic Diverticular Bleeding

Evaluation of Efficacy and Safety of Endoscopic Hemostasis with PuraStat in Colonic Diverticular Bleeding - Hemostasis with PuraStat in diverticular bleeding

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053065

Enrollment

Registered

2023-12-11

Start date

2022-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonic diverticular bleeding

Interventions

Endoscopic hemostasis with PureStat for colonic diverticular bleeding

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with colonic diverticular bleeding treated with endoscopic hemostasis using PuraStat

Exclusion criteria

Exclusion criteria: Patients with colonic diverticular bleeding treated with endoscopic hemostasis without Purastat

Design outcomes

Primary

Measure	Time frame
Rebleeding rate within 30 days after endoscopic hemostasis	—

Countries

Japan

Contacts

Public ContactDaisuke Yamaguchi

National Hospital Organization Ureshino Medical Center Gastroenterology

daisukehawks@gmail.com0954-43-1120

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026